Rectangle Acetate Prescription Eyeglasses

MODEL: QSZ5612

Color:
Black
Precio regular $39.90 USD
Tamaño del marco:
Medium Fit · 54 mm
Carta del tamaño
En stock
Select Lens and Purchase

Lens Options

5 available
Single Vision Everyday clarity
Blue Light Screen comfort
Photochromic Light adaptive
Progressive Multi-distance
Sunglasses Sun protection

LENS OPTIONS

Single Vision
Blue Light
Photochromic
Progressive
Sunglasses

Lens pricing varies by prescription and selected options.

Specifications

Square Acetate Eyeglasses - QSZ5612 size guide
Model

QSZ5612

Frame Material

Acetate

Frame Weight (approx)

38 g

Frame Fitting

Medium Face

Product Feature
  • Classic
  • Fashion
  • Skin-friendly
  • High-prescription
  • Professional
  • Business Style
  • Unique

Descripción del Producto

QSZ5612, Make a bold statement with these square-rimmed frames, blending vintage character with high-end craftsmanship. Featuring premium black acetate and distinctive silver-tone metallic accents on the wide temples, this design offers a commanding yet sophisticated presence. Engineered for versatility, these frames easily accommodate a wide prescription range from +12.00 to -12.00. Perfect for those seeking industrial elegance and functional durability, they are the ideal accessory for a sharp, professional, and lasting look.

MiGAFAS QSZ5612 black rectangular acetate prescription glasses, front view

Premium Packaging

Every frame includes our complete care kit. Order now to receive a free premium eyewear case with your purchase. Limited time only, while supplies last.

PRESCRIPTION GLASSES, MADE SIMPLE

  1. CHOOSE YOUR FRAME 01CHOOSE YOUR FRAMEPick your style, color,
    and size.
  2. SELECT YOUR LENSES 02SELECT YOUR LENSESChoose your lens type
    and coatings.
  3. COMPLETE YOUR ORDER 03COMPLETE YOUR ORDERFill Out Now: Enter Details Email Later: Send Us Your Prescription
  4. MADE FOR YOU 04MADE FOR YOUStandard Lenses: 1-3 days Premium Lenses: 3-5 days
  5. DELIVERED TO YOU 05DELIVERED TO YOUShipping: 5-12 days

Subscribe to our newsletter